Longitudinal association of type 2 diabetes and insulin therapy with muscle parameters in the KORA-Age study
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Aims The aim of the current study was to investigate the association of type 2 diabetes (T2D) and insulin treatment with changes in muscle mass, muscle strength, and physical performance in older adults.Methods In 731 participants of the population-based KORA-Age study aged 74.6 ± 6.2 years (T2D: n = 118; insulin treatment: n = 20), skeletal muscle index (SMI [kg/m 2]), hand grip strength (GS [kg]), and a timed up and go test (TUG [s]) were performed at baseline and after a follow-up time of 3 years. The association of T2D and insulin therapy with changes in muscle parameters was analyzed using linear regression models.Results After adjustment for sex, age, BMI, physical activity, smoking, and multimorbidity, T2D was associated with the change in SMI during follow-up (β - 0.1 (95% CI - 0.3 to - 0.02) kg/m 2; p = 0.02), but not with a change in GS (β - 0.9 (95% CI - 1.9 to 0.04) kg) or TUG (β - 0.1 (95% CI - 0.7 to 0.5) s). Insulin therapy was positively associated with change in SMI (β 0.6 (95% CI 0.3-0.9) kg/m 2; p = 0.001), but not in GS (β - 1.6 (95% CI - 4.1 to 0.8) kg) or TUG (β 1.6 (95% CI - 0.2-3.4) s) in comparison with treatment with oral anti-diabetic medication alone.Conclusions Participants with T2D showed an accelerated decline in muscle mass compared to non-diabetic participants. Insulin therapy was associated with preserved muscle mass, but not muscle function parameters, indicating a discrepancy between muscle mass and function in this high-risk population.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While existing clinical trial and epidemiological data demonstrate a positive correlation between insulin use and measures related to sarcopenia,43–45”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimation of skeletal muscle mass by bioelectrical impedance analysis
Janssen, I., Heymsfield, S. B., Baumgartner, R. N., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.465 · Cited by 1,482
Anabolic signaling deficits underlie amino acid resistance of wasting, aging muscle
Cuthbertson, D., Smith, K., Babraj, J., Leese, G., Waddell, T., Atherton, P., Wackerhage, H., Taylor, P. M., & Rennie, M. J. (2005) · The FASEB Journal · doi:10.1096/fj.04-2640fje · Cited by 1,211
Insulin effects in muscle and adipose tissue
Dimitriadis, G., Mitrou, P., Lambadiari, V., Maratou, E., & Raptis, S. A. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70014-6 · Cited by 649
Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
Mesinovic, J., Zengin, A., De Courten, B., Ebeling, P. R., & Scott, D. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s186600 · Cited by 553
The physical activity scale for individuals with physical disabilities: Development and evaluation
Washburn, R. A., Zhu, W., McAuley, E., Frogley, M., & Figoni, S. F. (2002) · Archives of Physical Medicine and Rehabilitation · doi:10.1053/apmr.2002.27467 · Cited by 458
Insulin resistance of muscle protein metabolism in aging
Rasmussen, B. B., Fujita, S., Wolfe, R. R., Mittendorfer, B., Roy, M., Rowe, V. L., & Volpi, E. (2006) · The FASEB Journal · doi:10.1096/fj.05-4607fje · Cited by 402
Oberbach, A., Bossenz, Y., Lehmann, S., Niebauer, J., Adams, V., Paschke, R., Schön, M. R., Blüher, M., & Punkt, K. (2006) · Diabetes Care · doi:10.2337/diacare.29.04.06.dc05-1854 · Cited by 385
Phielix, E., Schrauwen-Hinderling, V. B., Mensink, M., Lenaers, E., Meex, R., Hoeks, J., Kooi, M. E., Moonen-Kornips, E., Sels, J.-P., Hesselink, M. K. C., et al. (2008) · Diabetes · doi:10.2337/db08-0391 · Cited by 359
Intramuscular adipose tissue, sarcopenia, and mobility function in older individuals
Marcus, R. L., Addison, O., Dibble, L. E., Foreman, K. B., Morrell, G., & LaStayo, P. (2012) · Journal of Aging Research · doi:10.1155/2012/629637 · Cited by 296
Role of muscle mass and muscle quality in the association between diabetes and gait speed
Volpato, S., Bianchi, L., Lauretani, F., Lauretani, F., Bandinelli, S., Guralnik, J. M., Zuliani, G., & Ferrucci, L. (2012) · Diabetes Care · doi:10.2337/dc11-2202 · Cited by 294
Hyperglycemia Predicts Persistently Lower Muscle Strength With Aging
Kalyani, R. R., Metter, E. J., Egan, J., Golden, S. H., & Ferrucci, L. (2015) · Diabetes Care · doi:10.2337/dc14-1166 · Cited by 236
Boettcher, M., Machann, J., Stefan, N., Thamer, C., Häring, H., Claussen, C. D., Fritsche, A., & Schick, F. (2009) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.21754 · Cited by 214
Wilkes, E. A., Selby, A. L., Atherton, P. J., Patel, R., Rankin, D., Smith, K., & Rennie, M. J. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27543 · Cited by 204
Insulin Resistance of Protein Metabolism in Type 2 Diabetes
Pereira, S., Marliss, E. B., Morais, J. A., Chevalier, S., & Gougeon, R. (2008) · Diabetes · doi:10.2337/db07-0887 · Cited by 197
Andreassen, C. S., Jakobsen, J., & Andersen, H. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1237 · Cited by 178
Muscle dysfunction in type 2 diabetes: a major threat to patient’s mobility and independence
Bianchi, L., & Volpato, S. (2016) · Acta Diabetologica · doi:10.1007/s00592-016-0880-y · Cited by 173
Biomarkers for the Prediction of Type 2 Diabetes and Cardiovascular Disease
Herder, C., Karakas, M., & Koenig, W. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.93 · Cited by 168
Fujita, S., Glynn, E. L., Timmerman, K. L., Rasmussen, B. B., & Volpi, E. (2009) · Diabetologia · doi:10.1007/s00125-009-1430-8 · Cited by 164
Yoon, J. W., Ha, Y.-C., Kim, K. M., Moon, J. H., Choi, S. H., Lim, S., Park, Y. J., Lim, J. Y., Kim, K. W., Park, K. S., et al. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.2.140 · Cited by 149
Kalyani, R. R., Tra, Y., Yeh, H., Egan, J. M., Ferrucci, L., & Brancati, F. L. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12204 · Cited by 147
Autenrieth, C. S., Kirchberger, I., Heier, M., Zimmermann, A.-K., Peters, A., Döring, A., & Thorand, B. (2013) · Preventive Medicine · doi:10.1016/j.ypmed.2013.02.014 · Cited by 127
Self-citationSarcopenia: a potential cause and consequence of type 2 diabetes in Australia's ageing population?
Scott, D., Courten, B., & Ebeling, P. R. (2016) · Medical Journal of Australia · doi:10.5694/mja16.00446 · Cited by 119
Mavros, Y., Kay, S., Anderberg, K. A., Baker, M. K., Wang, Y., Zhao, R., Meiklejohn, J., Climstein, M., O’Sullivan, A., de Vos, N., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2196 · Cited by 118
Peters, A., Döring, A., Ladwig, K., Meisinger, C., Linkohr, B., Autenrieth, C. S., Baumeister, S., Behr, J., Bergner, A., Bickel, H., et al. (2011) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-011-0245-7 · Cited by 97
Self-citationCetrone, M., Mele, A., & Tricarico, D. (2014) · Current Diabetes Reviews · doi:10.2174/1573399810666140918121022 · Cited by 95
Hooper, L., Bunn, D. K., Abdelhamid, A. S., Gillings, R., Jennings, A., Maas, K., Millar, S., Twomlow, E. L., Hunter, P. R., Shepstone, L., et al. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.119925 · Cited by 93
Kalyani, R. R., Metter, E. J., Ramachandran, R., Chia, C. W., Saudek, C. D., & Ferrucci, L. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr022 · Cited by 86
Kang, S.-Y., Lim, G. E., Kim, Y. K., Kim, H. W., Lee, K., Park, T.-J., & Kim, J. (2017) · Journal of Bone Metabolism · doi:10.11005/jbm.2017.24.1.9 · Cited by 69
Sarcopenia – Endocrinological and Neurological Aspects
Stangl, M. K., Böcker, W., Chubanov, V., Ferrari, U., Fischereder, M., Gudermann, T. W., Hesse, E., Meinke, P., Reincke, M., Reisch, N., et al. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0672-1007 · Cited by 68
Self-citationInsulin Treatment Attenuates Decline of Muscle Mass in Japanese Patients with Type 2 Diabetes
Bouchi, R., Fukuda, T., Takeuchi, T., Nakano, Y., Murakami, M., Minami, I., Izumiyama, H., Hashimoto, K., Yoshimoto, T., & Ogawa, Y. (2017) · Calcified Tissue International · doi:10.1007/s00223-017-0251-x · Cited by 64
Koo, B. K., Roh, E., Yang, Y. S., & Moon, M. K. (2016) · Journal of Diabetes Investigation · doi:10.1111/jdi.12392 · Cited by 48
Cited by
Perturbed BMP signaling and denervation promote muscle wasting in cancer cachexia
Sartori, R., Hagg, A., Zampieri, S., Armani, A., Winbanks, C. E., Viana, L. R., Haidar, M., Watt, K. I., Qian, H., Pezzini, C., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aay9592 · Cited by 167
Massimino, E., Izzo, A., Riccardi, G., & Della Pepa, G. (2021) · Cells · doi:10.3390/cells10081958 · Cited by 102
“Epidemiological evidence and the clinical trial available suggest the beneficial association between insulin use and parameters of sarcopenia [87,95,96], indicating that a possible prescription of exogenous insulin could improve insulin signaling in the skeletal muscle, promote protein synthesis, and protect against t…”
BackgroundAnti‐diabetic drugs and sarcopenia: emerging links, mechanistic insights, and clinical implications
Zhang, X., Zhao, Y., Chen, S., & Shao, H. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12838 · Cited by 92
“More recently, a longitudinal study of insulin therapy with changes in muscle parameters showed that insulin preserved muscle mass, but not muscle function as assessed by hand grip strength.(25) However, it is noteworthy that several early clinical studies examining insulin therapy and body composition have shown that…”
BackgroundHou, Y., Xiang, J., Wang, B., Duan, S., Song, R., Zhou, W., Tan, S., & He, B. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1263650 · Cited by 82
Vendrell, C. S., Tercero, E. G., Hernández, J. B. M., & Cedeño‐Veloz, B. A. (2023) · Nutrients · doi:10.3390/nu15194149 · Cited by 55
“These drugs vary in their (Figure 3): While numerous studies have attempted to evaluate the effects of glucose-lowering medications on sarcopenia While numerous studies have attempted to evaluate the effects of glucose-lowering medications on sarcopenia [ [ 20 20 – –41 41 ], ], these these levels.”
Background
Metadata
- Authors
- Ferrari, U., Then, C., Rottenkolber, M., Selte, C., Seissler, J., Conzade, R., Linkohr, B., Peters, A., Drey, M., & Thorand, B.
- Affiliations
- LMU Klinikum (DE)
- Helmholtz Munich (DE)
- Corresponding author
- Ferrari, Uta
- ORCID
- Venue
- Acta Diabetologica
- Published
- 2020-04-04
- Volume
- 57
- Issue
- 9
- Pages
- 1057-1063
- ISSN
- 0940-5429 (ISSN-L)
- 1432-5233
- OpenAlex
- W3014427335
- Cited by
- 52
- References
- 31
- Citations by year
- 2026: 3 · 2025: 12 · 2024: 7 · 2023: 14 · 2022: 7 · 2021: 8 · 2020: 1
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Acta Diabetologica (publishedVersion)
- PubMed (publishedVersion)
- Site cant be reached (submittedVersion, other-oa)
- Funders
- Bundesministerium für Bildung und Forschung (FKZ 01ET0713, 01ET1003A)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, insulin therapy, skeletal muscle mass, muscle strength, physical performance, older adults, muscle mass loss, grip strength, Timed Up and Go test, skeletal muscle index, KORA-Age study
- MeSH terms
- Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Postural Balance, Female, Follow-Up Studies, Germany, Humans, Insulin, Longitudinal Studies, Male, Risk Factors, Time and Motion Studies, Exercise, Geriatric Assessment, Muscle, Skeletal, Hand Strength, Muscle Strength, Sarcopenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.